RxSight (RXST) Gross Profit (2020 - 2026)

RxSight (RXST) has 7 years of Gross Profit data on file, last reported at $23.5 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 17.05% year-over-year to $23.5 million; the trailing twelve-month figure through Mar 2026 stood at $98.2 million (down 7.89% YoY), and the FY2025 full-year result was $103.0 million, up 4.11% from the prior year.
• Gross Profit for Q1 2026 stood at $23.5 million, down from $25.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $28.8 million in Q4 2024 and bottomed at $3.8 million in Q1 2022.
• The 5-year median for Gross Profit is $20.7 million (2024), against an average of $17.7 million.
• The widest annual swing landed in 2022, when Gross Profit surged 689.66%; it then decreased 17.05% in 2026.
• A 5-year view of Gross Profit shows it stood at $7.4 million in 2022, then surged by 137.86% to $17.7 million in 2023, then soared by 63.07% to $28.8 million in 2024, then decreased by 12.24% to $25.3 million in 2025, then dropped by 6.99% to $23.5 million in 2026.
• The last three Gross Profit figures came in at $23.5 million (Q1 2026), $25.3 million (Q4 2025), and $24.2 million (Q3 2025), per Business Quant data.

Peer Comparison